Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000205559 | SCV000259734 | likely benign | Gorlin syndrome | 2025-01-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001026226 | SCV001188564 | likely benign | Hereditary cancer-predisposing syndrome | 2023-07-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV001026226 | SCV002535182 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-09-30 | criteria provided, single submitter | curation | |
Baylor Genetics | RCV003462369 | SCV004206640 | uncertain significance | Basal cell carcinoma, susceptibility to, 1 | 2023-05-24 | criteria provided, single submitter | clinical testing |